Predict your next investment

HEALTHCARE | Drug Development
onkaido.com

See what CB Insights has to offer

Total Raised

$20M

Investors Count

1

Onkaido Therapeutics Funding, Onkaido Therapeutics Valuation & Onkaido Therapeutics Revenue

3 Fundings

Onkaido Therapeutics's latest funding round was a Merger for on September 14, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/14/2017

Merger

1

1/14/2014

Corporate Minority

$99M

10

1/14/2014

Spinoff / Spinout

10

Date

9/14/2017

1/14/2014

1/14/2014

Round

Merger

Corporate Minority

Spinoff / Spinout

Amount

$99M

Investors

Valuation

Revenue

Sources

1

10

10

Onkaido Therapeutics Investors

1 Investors

Onkaido Therapeutics has 1 investors. Moderna Therapeutics invested in Onkaido Therapeutics's Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/14/2014

9/14/2017

3
Corporate Minority, Spinoff / Spinout (2014), Merger (2017)

Corporation

Massachusetts

First funding

1/14/2014

Last Funding

9/14/2017

Investor

Rounds

3
Corporate Minority, Spinoff / Spinout (2014), Merger (2017)

Board Seats

Type

Corporation

Location

Massachusetts

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.